SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 22nd, 2020 • OncBioMune Pharmaceuticals, Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 22nd, 2020 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 16, 2020, between OncBioMune Pharmaceuticals, Inc., a Nevada corporation (the “Company”), and Doug Mergenthaler (the “Purchaser”).